Background: Guidelines recommend that agents other than vancomycin be considered for some types of infection due to methicillin-resistant Staphylococcus aureus ... TMP/SMX treatment and mortality ...
The rapid emergence of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA ... that compare various antibiotics for the treatment of different types of infections.
including infections caused by methicillin-resistant Staphylococcus aureus (MRSA) Dalbavancin is under development for the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections, ...
Testing market is projected to expand steadily over the next decade, rising from an estimated USD 4.3 billion in 2025 to USD ...
MRSA - or methicillin resistant staphylococcus aureus - has already become resistant to most common antibiotics, making it difficult to treat with drugs. Once it gets into the body, through wounds ...
91). Figure 4: Comparison of the methicillin resistance cassettes that are typical of hospital- or community-acquired methicillin-resistant Staphylococcus aureus. S. aureus is an extraordinarily ...
which are challenging to treat. Methicillin-resistant Staphylococcus aureus (MRSA) is one such infection. This guide will explain what MRSA is; how you get it; if it's contagious; and its main ...
HY-133 is under clinical development by HyPharm and currently in Phase I for Methicillin-Resistant Staphylococcus aureus (MRSA) Infections. According to GlobalData, Phase I drugs for ...
Alternative treatments may be costly and ... In 1962, the first case of methicillin-resistant Staphylococcus aureus (MRSA) was identified. Resistance of certain bacteria to other antibiotics was also ...
Superbugs are microorganisms – not just bacteria, but also viruses, parasites, and fungi – that can cause infectious diseases ...